Alchemab Therapeutics Ltd

📍 London, United Kingdom🗓 Founded 2019👥 58 employees💰 Last funded Jul 2020
Biotechnology Research🌐 alchemab.com
Website LinkedIn
Alchemab is harnessing the naturally protective power of patient antibodies to keep people free of hard-to-treat disease in a unique and transformative approach to drug discovery and development. Alchemab takes an unbiased and function-first approach using three complementary processes and cutting-edge technologies to identify naturally protective antibodies. Alchemab’s engine is enabled through collaborations with patient representative groups and biobanks around the world with whom we partner to further our understanding of disease.
1
Total investors
1
Early stage
0
Mid stage
0
Late stage
2019
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United Kingdom
1
Frequently asked questions
Who invested in Alchemab Therapeutics Ltd?
Alchemab Therapeutics Ltd has 1 investors on record on gritt.io, including 1 early-stage backers.
When did Alchemab Therapeutics Ltd last raise funding?
The most recent investment in Alchemab Therapeutics Ltd recorded on gritt.io was in July 2020.
When was Alchemab Therapeutics Ltd founded?
Alchemab Therapeutics Ltd was founded in 2019.
What industry is Alchemab Therapeutics Ltd in?
Alchemab Therapeutics Ltd operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Alchemab Therapeutics Ltd based?
Alchemab Therapeutics Ltd is headquartered in London, United Kingdom.